Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2022 IKCS: Europe
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Trial-in-progress Abstract
Home
Trial-in-progress Abstract
Trial-in-progress Abstract
Type here to filter the list
28: A Three-Arm Randomized Multicenter Phase II Trial Comparing Patient-Reported Outcome (PRO) Monitoring in Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma: ePRO vs paper-PRO, or usual care (Trial in Progress)
Favorite
29: LITESPARK-011: Belzutifan Plus Lenvatinib Versus Cabozantinib: A Randomized, Open-Label Phase 3 Study in Patients With Advanced Renal Cell Carcinoma (RCC) After Anti–PD-1/PD-L1 Therapy
Favorite
30: Trial in Progress: Individualized Treatment Strategy for Patients with Metastatic Non-clear Cell Renal Cell Carcinoma – the INDIGO phase II study
Favorite
31: AURORAX-0087A: Glycosaminoglycan (GAG) scores for recurrence detection in Leibovich Points ≥5 clear cell renal cell carcinoma - Trial In Progress
Favorite